Literature DB >> 16721663

Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis.

Joseph J Wakshlag1, Marc A Antonyak, Jason E Boehm, Karen Boehm, Richard A Cerione.   

Abstract

Tissue transglutaminase (TGase) has been implicated in both cell survival and apoptosis. Here we investigate the role of TGase in beta-amyloid-induced neurotoxicity using retinoic acid (RA)-differentiated, neuronal SH-SY5Y cells. We show that beta-amyloid-induced cell death was reduced in RA-differentiated SH-SY5Y cells treated with the TGase inhibitor monodansyl cadaverine. Expression of wild-type TGase enhanced beta-amyloid1-42-induced apoptosis, whereas transamidation-defective TGase did not. These effects were specific for beta-amyloid-treated cells, as TGase reversed the neurotoxic effects caused by hydrogen peroxide treatment. Enhancement of beta-amyloid1-42-induced cell death by TGase was accompanied by marked increases in TGase activity in the membrane fractions and translocation of TGase to the cell surface. Overall, these findings suggest that the ability of TGase to exhibit pro-survival versus pro-apoptotic activity is linked to its cellular localization, with beta-amyloid-induced recruitment of TGase to the cell surface accentuating neuronal toxicity and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721663     DOI: 10.1007/s10930-006-0009-1

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  34 in total

1.  Tissue-transglutaminase in rat and human brain: light and electron immunocytochemical analysis and in situ hybridization study.

Authors:  N Maggio; S Sellitti; C P Capano; M Papa
Journal:  Brain Res Bull       Date:  2001 Oct-Nov 1       Impact factor: 4.077

2.  Transglutaminase activity is increased in Alzheimer's disease brain.

Authors:  G V Johnson; T M Cox; J P Lockhart; M D Zinnerman; M L Miller; R E Powers
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

Review 3.  Transglutaminases.

Authors:  J E Folk
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

4.  Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.

Authors:  Jason E Boehm; Ugra Singh; Carolyn Combs; Marc A Antonyak; Richard A Cerione
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

5.  Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells.

Authors:  Marc A Antonyak; Allison M Miller; Jaclyn M Jansen; Jason E Boehm; Cheryl E Balkman; Joseph J Wakshlag; Rodney L Page; Richard A Cerione
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

6.  Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death.

Authors:  Tamara Milakovic; Janusz Tucholski; Eric McCoy; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

7.  Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.

Authors:  S M Dudek; G V Johnson
Journal:  Brain Res       Date:  1994-07-18       Impact factor: 3.252

8.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

9.  Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis.

Authors:  Elena Tamagno; Maurizio Parola; Michela Guglielmotto; Gianni Santoro; Paola Bardini; Laura Marra; Massimo Tabaton; Oliviero Danni
Journal:  Free Radic Biol Med       Date:  2003-07-01       Impact factor: 7.376

10.  Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.

Authors:  Rulin Zhang; Tammy-Lynn Tremblay; Angela McDermid; Pierre Thibault; Danica Stanimirovic
Journal:  Glia       Date:  2003-04-15       Impact factor: 7.452

View more
  6 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.

Authors:  Adrien W Schmid; Enrico Condemi; Gabriele Tuchscherer; Diego Chiappe; Manfred Mutter; Horst Vogel; Marc Moniatte; Yury O Tsybin
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

3.  Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation.

Authors:  Dean M Hartley; Chaohui Zhao; Austin C Speier; Gavitt A Woodard; Shaomin Li; Zongli Li; Thomas Walz
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

4.  Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation.

Authors:  Jin-Haeng Lee; Jaeho Jeong; Eui Man Jeong; Sung-Yup Cho; Jeong Wook Kang; Jisun Lim; Jinbeom Heo; Hyunsook Kang; In-Gyu Kim; Dong-Myung Shin
Journal:  Int J Mol Med       Date:  2014-01-30       Impact factor: 4.101

5.  Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice.

Authors:  Micha M M Wilhelmus; Osoul Chouchane; Maarten Loos; Cornelis A M Jongenelen; John J P Brevé; Allert Jonker; John G J M Bol; August B Smit; Benjamin Drukarch
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-23       Impact factor: 6.250

6.  Di-tyrosine cross-link decreases the collisional cross-section of aβ peptide dimers and trimers in the gas phase: an ion mobility study.

Authors:  Ewa Sitkiewicz; Jacek Olędzki; Jarosław Poznański; Michał Dadlez
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.